已核实 DOI PubMed 相关产品: 28

Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice

Journal 2023 · IF 16.6 · 14(1): 1-18 · 发表于 2023 年 3 月 2 日
作者: Wu Yandi,Huang Tongsheng,Li Xinghui,Shen Conghui,Ren Honglin,Wang Haiping,Wu Teng,Fu Xinlu,Deng Shijie,Feng Ziqi,Xiong Shijie,Li Hui,Gao Saifei,Yang Zhenyu,Gao Fei,Dong Lele,Cheng Jianding,Cai Weibin
阅读全文 在 PubMed 查看

摘要

Diabetic cardiomyopathy is a primary myocardial injury induced by diabetes with complex pathogenesis. In this study, we identify disordered cardiac retinol metabolism in type 2 diabetic male mice and patients characterized by retinol overload, all-trans retinoic acid deficiency. By supplementing type 2 diabetic male mice with retinol or all-trans retinoic acid, we demonstrate that both cardiac retinol overload and all-trans retinoic acid deficiency promote diabetic cardiomyopathy. Mechanistically, by constructing cardiomyocyte-specific conditional retinol dehydrogenase 10-knockout male mice and overexpressing retinol dehydrogenase 10 in male type 2 diabetic mice via adeno-associated virus, we verify that the reduction in cardiac retinol dehydrogenase 10 is the initiating factor for cardiac retinol metabolism disorder and results in diabetic cardiomyopathy through lipotoxicity and ferroptosis. Therefore, we suggest that the reduction of cardiac retinol dehydrogenase 10 and its mediated disorder of cardiac retinol metabolism is a new mechanism underlying diabetic cardiomyopathy.

本研究中使用的阿拉丁产品

28 款产品在本文中被引用